tracking

More InfoScotland sites:

Together we can fight cervical cancer

Having the immunisation

Scotland’s new Human Papilloma Virus (HPV) immunisation programme offers girls aged 12 to 13, in their second year of secondary school (S2), the chance to be protected against the most common cause of cervical cancer.

There is also a three-year one-off ‘catch-up’ campaign to immunise girls aged 13 to 17 so older age groups can also benefit from the vaccine as soon as possible.

If you are a parent, or carer, there are some frequently asked questions (FAQs) to help you discuss HPV immunisation with your daughter.

How the vaccine is given

Health boards are delivering the new HPV vaccine in different ways; most girls will receive their jab at school, but if you’ve left school you will be contacted by your local NHS.

Participating in the programme

Having the HPV jab is a personal choice — you, or your parent or carer, will be asked to sign a consent form before the first HPV immunisation session.

Vaccine information

This is a new vaccine — find out more about it.

Side effects

Information about possible side effects of the vaccine.

Allergies

Information for girls who may have allergies.

Frequently asked questions

Try our introductory answers to frequently asked questions about cervical cancer, giving consent and the new HPV vaccine. Should you have any further questions, please go to our Contact us page.

Section navigation:

Phone the free NHS helpline for impartial advice and information

Work 0800 22 44 88

Textphone
18001 22 44 88

8.00am-10.00pm
7 days a week

Celebrities have their say

Find out why   is giving her support to the campaign.

Am I eligible?

The routine immunisation programme in Scotland is for girls aged 12 and 13 (in secondary school year S2). Enter your age and gender to find out if you are eligible for the HPV vaccine.

Ready Reckoner

Personal stories

Ailsa's Story

Ailsa, Scotland

Find out how Ailsa feels about being offered the new HPV vaccine. See what her Mum has to say, in Mags' story.